A 29-year-old woman with a history of systemic lupus erythematosus (SLE) presented to our medical center with 9 days of worsening left wrist and hand cellulitis and ulceration unresponsive to broad-spectrum antibiotics including cefepime, linezolid, and ciprofloxacin (Panel A). Concurrent immune modulation therapy included pulse dose methylprednisolone. Prior to hospitalization she was on maintenance dose hydroxychloroquine for SLE.
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In addition to concern of infection, vasculitic and thrombotic etiologies were also entertained. Both arterial and venous imaging studies were unremarkable. Given her unresponsiveness to broad-spectrum antibiotics and immune modulation therapy, a skin biopsy was obtained. Focal acute fibrinoid vasculitis was present in addition to acantholytic squamous epithelial cells showing viral inclusions consistent with acute herpes vasculitis (Panel B).
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Herpes-induced vasculitis in SLE patients is an extremely rare event. Herpes infection can have numerous complications, most commonly herpes ophthalmicus, and others include post-herpetic neuralgia, ulcers, glaucoma, motor paralysis and paresthesia. Cutaneous manifestations have also been described, namely scarring, lymphomas, 1 pseudolymphomas, 2 Kaposi's sarcoma, 3 granuloma annulare and tuberculoid granuloma. 4 Whether herpes-induced vasculitis in the lupus patient is a primary infection with herpes simplex virus, a reinfection, or related to a suppressed immunologic state is not yet known. Chronic cutaneous infection with herpes simplex virus in a patient with SLE was previously reported once. 5 In our patient, anti-viral medication, valacyclovir, was initiated and led to dramatic clinical improvement.
